drugset
Drugs / Conjugated Estrogens/Bazedoxifene
last change Jun 2024 re-read 3 minutes ago

Conjugated Estrogens/Bazedoxifene

also known as Duavee
Developed for
ductal breast carcinoma in situ
Investigated by
National Cancer Institute (NCI) · Northwestern University · Pfizer · University of California, San Francisco · University of Chicago

Trials 1

today NCT02694809 · Ph 2
20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02694809 Jan 2017 → Jun 2024 ductal breast carcinoma in situ Northwestern University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Conjugated Estrogens/Bazedoxifene ClinicalTrials.gov intervention name — accepted as the source's own label NCT02694809 ↗
Known as Duavee “conjugated estrogens/bazedoxifene (Duavee®) causes any changes in the proliferation markers within the breast tissue of the study subjects.” NCT02694809 ↗